FDA Approved: ZIEXTENZO — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for ZIEXTENZO (pegfilgrastim-bmez) filed by Sandoz Inc, indicating a labeling update or indication expansion for the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• Ziextenzo (pegfilgrastim)

Snippet

SUPPL AP for ZIEXTENZO (PEGFILGRASTIM-BMEZ)